No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population

Psychiatric Genetics

Volumn 15, Issue 4, 2005, Pages 299-301

  Ham, Byung Joo ^a   Lee, Min Soo ^b,e   Lee, Heon Jeong ^b   Kang, Rhee Hun ^b   Han, Chang Su ^b   Choi, Myoung Jin ^b   Lee, Seung Hwan ^c   Ryu, Seung Ho ^d  

^a Hallym University Medical Center   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

Antidepressant response; Major depressive disorder; Polymorphism; Tryptophan hydroxylase

Indexed keywords

ANTIDEPRESSANT AGENT; MIRTAZAPINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN HYDROXYLASE; PRIMER DNA;

ADULT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DNA POLYMORPHISM; DOSE RESPONSE; DRUG ACTIVITY; EVALUATION; FEMALE; GENE FREQUENCY; GENOTYPE; HAMILTON SCALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATHOGENESIS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; DEPRESSION; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIDEPRESSIVE AGENTS; BASE SEQUENCE; DEPRESSIVE DISORDER; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRYPTOPHAN HYDROXYLASE;

EID: 33645744529     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200512000-00014     Document Type: Article

References (15)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association.
2. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, et al. (1998). Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55:33-37.
3. Boularand S, Darmon MC, Ganem Y, Launay JM, Mallet J (1990). Complete coding sequence of human tryptophan hydroxylase. Nucleic Acids Res 18:4257.
4. Craig SP, Boularand S, Darmon MC, Mallet J, Craig IW (1991). Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization. Cytogenet Cell Genet 56:157-159.
5. Evans J, Reeves B, Platt H, Leibenau A, Goldman D, Jefferson K, Nutt D (2000). Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med 30:1327-1334.
6. Hamilton M (1967). Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
7. Han OS, Hong JP (2000). Structured Clinical Interview for DSM-IV Axis I Disorder - Korean Version. Seoul: Hana Medical Publishing.
8. Ishiguro H, Saito T, Shibuya H, Toru M, Arinami T (1999). The 5′ region of the tryptophan hydroxylase gene: mutation search and association study with alcoholism. J Neural Transm 106:1017-1025.
9. Jonsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, et al. (1997). Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247:297-302.
10. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M (1994). Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 51:34-38.
11. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997). Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45:145-148.
12. Pickar D, Rubinow K (2001). Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci 22:75-83.
13. Serretti A, Zanardi R, Cusin C, Rossini D, Lorenzi C, Smeraldi E (2001a). Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol 11:375-380.
14. Serretti A, Zanardi R, Rossini D, Cusin C, Lilli R, Smeraldi E (2001b). Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry 6:586-592.
15. Yoshida K, Naito S, Takahashi H, Sato K, Ito K, Kamata M, et al. (2002). Monoamine oxidase: a gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 26:1279-1283.